YOKNEAM, Israel, May 18, 2016 (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced it will be collaborating with leading educational institutes, residents and fellows to provide training sessions for the state-of-the-art UltraPulse DUO and AcuPulse DUO surgical solutions, at the annual Combined Otolaryngology Spring Meetings (COSM), being held in Chicago from May 18-22, 2016.
Photos accompanying this announcement are available at
With its high microsurgical precision, the UltraPulse CO2 laser technology has been considered the industry’s gold standard solution for minimally invasive delicate procedures for more than a decade. The new UltraPulse DUO features the ultra-precise Digital AcuBlade scanning micromanipulator capability and superior fiber energy delivery all within the same platform, helping physicians achieve the master’s touch and improve patient care.
“The UltraPulse DUO features unique energy delivery capabilities, providing maximum control over desired clinical outcomes. The combination of the two modalities allows ENT surgeons to expand and operate beyond their line-of-sight and address clinical challenges which cannot be otherwise addressed by a platform with a single mode of energy delivery,” said Paul Castellanos, M.D., Associate Professor of Surgery at the University of Alabama at Birmingham. “With the system’s precision and clear margin visibility, I am better able to treat patients by preserving healthy, delicate tissue and provide patients with a safer and more efficient surgery experience.”
As an addition to the Lumenis DUO product family, the UltraPulse DUO joins the AcuPulse DUO, the first integrated CO2 laser system to deliver a combination of laser modalities. Providing a seamless adjustment between the two therapeutic modalities, both systems are accompanied by a wide range of surgical tools, along with cost effective fibers that feature renewable tips, aiming beam and high energy transmission. The versatile Lumenis DUO product line is designed for smart tissue management and for optimal treatment of hard-to-reach delicate anatomy.
COSM conference attendees are invited to join UltraPulse DUO and AcuPulse DUO training sessions to obtain first-hand experience with the latest head and neck surgical innovations. As part of its ongoing commitment to focus on better patient care, Lumenis will also be hosting the “Leave No Disease Behind” challenge, in which residents and fellows have the opportunity to experience the precision of Lumenis CO2 laser surgical solutions. Lumenis will sponsor the winner of the challenge to attend and participate in Memorial Sloan Kettering’s Hands–on Transoral Laser Microsurgery for Head and Neck Cancer Course.
“For 50 years, Lumenis has been dedicated to developing advanced products and delivering innovative solutions. Our comprehensive approach includes not only providing the best-in-class products, but also partnering with leading educational institutions to positively impact the quality of patient care,” said Tzipi Ozer-Armon, CEO of Lumenis. “Thousands of patients all over the world have experienced improved care from surgeons who enhance their surgical capabilities with Lumenis’ innovative CO2 laser technology solutions, and we look forward to continuing our legacy with our commitment to educate the next generation of healthcare professionals.”
To learn more about Lumenis and its portfolio of ENT solutions, please visit the COSM booth #410.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit: www.lumenis.com
For further information: Glenn Silver Lazar Partners Ltd. (646) 871-8495